Sangamo Therapeutics logo
Sangamo Therapeutics SGMO
report update icon

Quarterly report 2026-Q1
added 05-14-2026

Sangamo Therapeutics Operating Expenses | SGMO

Annual Operating Expenses Sangamo Therapeutics

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
161 M 162 M 450 M 313 M 294 M 248 M 208 M 162 M 92.9 M 91.9 M 86.4 M 72.4 M 50.8 M 43.9 M 46.1 M 45.7 M 41.6 M -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
450 M 41.6 M 151 M

Quarterly Operating Expenses Sangamo Therapeutics

2026-Q1 2025-Q3 2025-Q2 2025-Q1 2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
33.4 M 36.1 M 36.2 M 36.1 M 38.8 M 37.4 M 52 M 116 M 130 M 140 M - 81.4 M 75.1 M 73.5 M - 77 M 76.6 M 72.6 M 69.2 M 61.5 M 59.4 M 57.6 M 53.4 M 51.2 M 51.1 M 52 M 47.6 M 39.8 M 40.6 M 33.6 M 26.8 M 24.8 M 21 M 20.2 M 18.8 M 22 M 30.5 M 20.6 M 24.8 M 21.3 M 20.6 M 19.7 M 19.4 M 20.1 M 17.4 M 15.7 M 15 M 11.9 M 12.4 M 11.5 M 12.3 M 10.7 M 10.3 M 10.5 M 11.1 M 11.4 M 11.8 M 11.8 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
140 M 10.3 M 39.5 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer Operating Expenses Price % 24h Market Cap Country
Repare Therapeutics Repare Therapeutics
RPTX
147 M - - $ 112 M canadaCanada
Sesen Bio Sesen Bio
SESN
81.8 M - 7.29 % $ 127 M usaUSA
Windtree Therapeutics Windtree Therapeutics
WINT
26.1 M - - $ 26.8 M usaUSA
Trean Insurance Group Trean Insurance Group
TIG
-121 K - - $ 316 M usaUSA
SQZ Biotechnologies Company SQZ Biotechnologies Company
SQZ
102 M - 57.95 % $ 12.8 M usaUSA
MEI Pharma MEI Pharma
MEIP
17.5 M - 10.43 % $ 20.5 M usaUSA
Palatin Technologies Palatin Technologies
PTN
21.9 M - - $ 13 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
629 M - - - russiaRussia
Lyra Therapeutics Lyra Therapeutics
LYRA
31.4 M - - $ 24.9 M usaUSA
Brickell Biotech Brickell Biotech
BBI
14.4 M - -5.38 % $ 6.06 M usaUSA
Applied Therapeutics Applied Therapeutics
APLT
105 M - - $ 8.42 M usaUSA
ESSA Pharma ESSA Pharma
EPIX
34.4 M - - $ 8.86 M canadaCanada
Generation Bio Co. Generation Bio Co.
GBIO
162 M - - $ 344 M usaUSA
Clearside Biomedical Clearside Biomedical
CLSD
33.1 M - - $ 25.3 M usaUSA
Merus N.V. Merus N.V.
MRUS
308 M - - $ 5.78 B niderlandNiderland
RAPT Therapeutics RAPT Therapeutics
RAPT
136 M - - $ 2.36 B usaUSA
Annexon Annexon
ANNX
216 M $ 3.11 -8.94 % $ 482 M usaUSA
Acasti Pharma Acasti Pharma
ACST
11.1 M - 4.01 % $ 150 M canadaCanada
Aptose Biosciences Aptose Biosciences
APTO
24.7 M - -45.71 % $ 1.2 M canadaCanada
Galapagos NV Galapagos NV
GLPG
787 M - - $ 1.83 B belgiumBelgium
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
754 K - -4.36 % $ 27 M usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
4.49 M - -52.27 % $ 4.45 M usaUSA
Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd.
GLMD
8.51 M $ 4.63 21.05 % $ 20 M israelIsrael
Achieve Life Sciences Achieve Life Sciences
ACHV
16.5 M $ 6.78 0.89 % $ 296 M usaUSA
Leap Therapeutics Leap Therapeutics
LPTX
41.1 M - 368.57 % $ 41.9 M usaUSA
Lumos Pharma Lumos Pharma
LUMO
38.7 M - - $ 35.3 M usaUSA
Gamida Cell Ltd. Gamida Cell Ltd.
GMDA
48.2 M - -18.25 % $ 5.04 M israelIsrael
Axcella Health Axcella Health
AXLA
77 M - -16.42 % $ 249 M usaUSA
Metacrine Metacrine
MTCR
61.1 M - - $ 24.2 M usaUSA
Zealand Pharma A/S Zealand Pharma A/S
ZEAL
1.23 B - 0.52 % $ 821 M danmarkDanmark
Myovant Sciences Ltd. Myovant Sciences Ltd.
MYOV
187 M - -0.04 % $ 2.62 B usaUSA
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
22.4 M - -74.18 % $ 955 K usaUSA
Idera Pharmaceuticals Idera Pharmaceuticals
IDRA
32.7 M - -23.04 % $ 26.6 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
285 M - - $ 3.67 B usaUSA
Verona Pharma plc Verona Pharma plc
VRNA
197 M - - $ 69.7 B britainBritain
Atreca Atreca
BCEL
98.7 M - -11.76 % $ 5.79 M usaUSA
Guardion Health Sciences Guardion Health Sciences
GHSI
9.73 M - -0.31 % $ 3.64 M usaUSA
Opiant Pharmaceuticals Opiant Pharmaceuticals
OPNT
42.6 M - - $ 109 M usaUSA
Akouos Akouos
AKUS
86.8 M - 0.23 % $ 488 M usaUSA
ImmunoGen ImmunoGen
IMGN
330 M - - $ 7.92 B usaUSA
Vascular Biogenics Ltd. Vascular Biogenics Ltd.
VBLT
14.8 M - -8.77 % $ 12.4 M israelIsrael
Cidara Therapeutics Cidara Therapeutics
CDTX
177 M - - $ 1.41 B usaUSA
Iterum Therapeutics Iterum Therapeutics
ITRM
18.7 M - - $ 591 K irlandaIrlanda
Virpax Pharmaceuticals Virpax Pharmaceuticals
VRPX
12.1 M - -45.12 % $ 2.85 M usaUSA
Navidea Biopharmaceuticals Navidea Biopharmaceuticals
NAVB
13.9 M - -2.99 % $ 2.47 M usaUSA
Stealth BioTherapeutics Corp Stealth BioTherapeutics Corp
MITO
46.3 M - - $ 23.9 M usaUSA
OncoSec Medical Incorporated OncoSec Medical Incorporated
ONCS
37 M - 31.87 % $ 1.61 M usaUSA